Endocr Rev June 2014 PMID 24423981

Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Harrison G Pope, Ruth I Wood, Alan Rogol, Fred Nyberg, Larry Bowers, Shalender Bhasin

Full text PDF Download social card

Mentions

Peak: 1 in May 2024

across 5 sources since May 2024

Extended reach

13,812

potential audience

Total likes

Video views

503

Mentions per month

May 2024 – Dec 2025

Where it's discussed

News38 articles
Facebook5 posts
YouTube3 videos
Blogs3 articles
X / Twitter1 posts

AI synopsis

What people are saying

Discussions highlight the recognition that performance-enhancing drugs affect not only athletes but also nonathletes, with phrases like 'not just for athletes anymore' signaling broad concern. The tone suggests a mix of acknowledgment and concern, emphasizing the need for increased awareness and research, which aligns with the article's call for more public health initiatives.

AgreementModerate agreement

Most posts recognize the importance of addressing PED use beyond just athletes, agreeing with the scientific statement’s broader public health message.

InterestHigh interest

Discussions demonstrate high curiosity and concern about the widespread implications of PED misuse, indicating strong interest.

EngagementModerate engagement

Posts reflect thoughtful reactions and some critical reflections on the health risks, showing moderate depth of engagement.

ImpactModerate impact

Posts suggest that the article influences perceptions of drug use risks, emphasizing its potential relevance to society at large.

Abstract in brief

The scientific statement highlights that while media focus is on elite athletes using performance-enhancing drugs (PEDs) to win, most users are nonathletes like weightlifters, and they often underestimate the health risks, which include deadly and chronic health issues.
PED use usually involves high doses, mixed substances, and other risky behaviors, leading to serious health problems such as cardiovascular, psychiatric, metabolic, endocrine, neurologic, infectious, hepatic, renal, and musculoskeletal disorders; however, most data come from observational studies due to ethical issues with experimental trials.
To better understand and address the public health impact of PEDs, the statement emphasizes the need for more research on prevalence, mechanisms of harm, interactions with injuries, and treatment options, as well as increasing public awareness about the dangers of PED use.]

Read the full abstract